Synjardy 5 mg/1

Synjardy 5 mg/1 tablets combine empagliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan. Learn about Synjardy's uses, effects, and precautions here.

Synjardy 5 mg/1 tablets are designed to help manage type 2 diabetes by improving blood sugar control. This combination medication is typically used alongside diet and exercise to support overall diabetes management. People often ask, 'What is Synjardy used for?'—it is primarily intended for adults with type 2 diabetes who require dual therapy to achieve optimal glycemic control.

Common effects of Synjardy 5 mg/1 tablets may include symptoms such as nausea, diarrhea, or urinary tract infections. Some individuals might experience changes in urination frequency or low blood sugar levels. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Synjardy 5 mg/1 tablets should be handled with care, especially for those with kidney issues, as empagliflozin can affect kidney function. It is also important to stay hydrated and monitor blood sugar levels regularly. Always follow the advice of a healthcare professional regarding the use of this medication.

Synjardy 5 mg/1 tablets may interact with certain medications, including diuretics, insulin, and other drugs that affect blood sugar levels. Alcohol consumption should be limited, as it can enhance the risk of low blood sugar. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.